Home | Welcome to Contract Pharma   
Last Updated Sunday, May 26 2013
Print

Industry News

Related Searches:

Filter by:

August 24, 2007
MedImmune has opened a new, state-of-the-art pilot lab facility at its Gaithersburg site headquarters. The facility features the latest equipment and process automation systems and will support the company's clinical product pipeline with additional…   Read More »
August 23, 2007
Pro-Pharmaceuticals, Inc. has retained Camargo Pharmaceutical Services to provide strategic regulatory support for the company’s 505(b)(2) submissions for Davanat with the FDA. Camargo’s regulatory support includes the preparation and sub…   Read More »
August 23, 2007
Cephalon, Inc. has signed an agreement to acquire the North American rights to Amrix (cyclobenzaprine hydrochloride extended-release capsules) from ECR Pharmaceuticals for $100 million cash. ECR is eligible to receive future cash payments based on th…   Read More »
August 23, 2007
GPC Biotech AG is restructuring and will reduce its U.S. staff by 46 employees (approximately 15%) with reductions in the commercialization, drug development and general and administrative groups. The company also announced that Martine George, M.D.…   Read More »
August 22, 2007
Pfizer broke ground on a $50 million expansion at its Chesterfield campus that reflects the company's increased investment in biopharmaceuticals. The expansion doubles the size of a pilot plant that produces protein-based, injectable biologic drugs f…   Read More »
August 21, 2007
ImClone Systems, Inc. received approval from the FDA for a second facility to manufacture Erbitux. This new 250,000-sq.-ft. multi-suite manufacturing facility, referred to as "BB50", more than doubles the company's total production capacity…   Read More »
August 21, 2007
Abraxis BioScience, Inc. and The Scripps Research Institute (TRSI) have entered an exclusive licensing agreement for the worldwide development and commercialization of an epothilone therapeutic for the treatment of cancer. Epothilones are a new class…   Read More »
August 20, 2007
Enzon Pharmaceuticals, Inc. is selling 25% interest in its royalty from PEG-INTRON, marketed by Schering-Plough Corp. for $92.5 million to Drug Royalty Corp., Inc. (DRC). Enzon is also eligible to receive an additional one-time milestone payment of $…   Read More »
August 17, 2007
Nexgen Pharma, Inc. has acquired certain assets of The Chemins Company, Inc. located in Colorado Springs, CO. The acquisition includes 250,000 sq. ft. of manufacturing, laboratory and warehouse/distribution space. Gary Korngold, Nexgen's execut…   Read More »
August 16, 2007
Amgen plans to reduce its headcount by 12-14% or 2,200-2,600 staff in an effort to "create operational efficiencies" and support R&D investments. These initiatives, expected to yield savings of between $1 billion - $1.3 billion in 2008,…   Read More »
August 16, 2007
Cell Therapeutics, Inc. will acquire Zevalin, the first FDA-approved radioimmunotherapy, from Biogen Idec. CTI will be responsible for marketing, sales, and development of the drug in the U.S. The drug will continue to be sold outside the U.S. by Bay…   Read More »
August 16, 2007
Pharmatek Laboratories, Inc. has added cytotoxic and high-potent drug development capabilities to its pharmaceutical chemistry development services. These services include: analytical method development, preformulation testing, formulation developmen…   Read More »
August 15, 2007
Millipore Corp. expanded its agreement with Novo Nordisk to provide recombinant human insulin, a key cell culture supplement used to manufacture biologic drugs. Under the terms of the agreement, Millipore will have exclusive worldwide rights to…   Read More »
August 15, 2007
Sancilio & Company, Inc. is expanding the analytical services offered through its FDA and DEA registered cGMP analytical chemistry lab at SCI's Riviera Beach, FL location. Dr. Nealie Newberger, formerly of the Analytical Services Lab at SCI,…   Read More »
August 10, 2007
Bilcare has begun a capital investment project in an effort to enhance its global footprint and increase capacity and capabilities. The company is upgrading its packaging, storage and distribution facilities at its U.S. headquarters in Phoenixville,…   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On